NCT01309139View on ClinicalTrials.gov

Pharmacokinetics of the Fixed Dose Combination of Tiotropium Plus BI 54903 Versus the Combination of the Monoproducts of Tiotropium and BI 54903 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

June 30, 2011

Conditions
Healthy
Interventions
DRUG

Tiotropium

Medium dose of oral inhalation

DRUG

Tiotropium

Medium dose of oral inhalation

DRUG

BI 54903

Medium dose of oral inhalation

DRUG

BI 54903

Medium dose of oral inhalation

Trial Locations (1)

Unknown

1298.2.1 Boehringer Ingelheim Investigational Site, Ingelheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01309139 - Pharmacokinetics of the Fixed Dose Combination of Tiotropium Plus BI 54903 Versus the Combination of the Monoproducts of Tiotropium and BI 54903 in Healthy Volunteers | Biotech Hunter | Biotech Hunter